News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
122 Results
Type
Article (13)
Press Release (109)
Section
Business (28)
Deals (5)
Drug Development (29)
FDA (2)
Job Trends (2)
News (64)
Policy (1)
Tag
Alliances (2)
Approvals (2)
Best Places to Work (3)
Clinical research (34)
Data (1)
Diabetes (2)
Earnings (6)
Events (30)
Executive appointments (2)
FDA (2)
Healthcare (1)
IPO (4)
Mergers & acquisitions (1)
Metabolic disorders (2)
Patient recruitment (1)
People (26)
Phase I (1)
Phase II (12)
Phase III (23)
Pipeline (1)
Postmarket research (2)
Regulatory (2)
Southern California (3)
United States (6)
Date
Last 30 days (5)
Last 365 days (38)
2024 (33)
2023 (37)
2022 (12)
2021 (5)
2020 (15)
2019 (3)
2018 (5)
2016 (1)
2015 (2)
2013 (1)
2012 (2)
2011 (3)
2010 (3)
Location
Asia (4)
Australia (1)
California (3)
Europe (98)
Massachusetts (1)
New Jersey (1)
North Carolina (1)
Southern California (3)
122 Results for "oculis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Oculis and EURETINA Announces the Ramin Tadayoni Award
Oculis Holding AG, a global biopharmaceutical company purposefully driven to save sight and improve eye care, announces, in collaboration with EURETINA, the Ramin Tadayoni Award.
June 27, 2024
·
3 min read
Genetown
Oculis to Participate at Upcoming April 2024 Investor Conferences
Oculis Holding AG, a global biopharmaceutical company purposefully driven to save sight and improve eye care, announced that Oculis’s management will be attending and presenting at the following upcoming investor conferences.
April 4, 2024
·
1 min read
Genetown
Oculis to Present at Bank of America Global Healthcare Conference
Oculis Holding AG a global biopharmaceutical company purposefully driven to save sight and improve eye care, announced that Oculis’ management will be attending and presenting at the Bank of America Healthcare Conference taking place on May 14-16, 2024 in Las Vegas, NV.
May 6, 2024
·
1 min read
Press Releases
Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer
October 2, 2024
·
4 min read
Press Releases
Oculis to Present at Upcoming September 2023 Investor Conferences
August 29, 2024
·
1 min read
Press Releases
Oculis’ DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024
October 15, 2024
·
10 min read
Oculis Reports Q1 2024 Financial Results and Provides Company Updates
Oculis Holding AG, a global biopharmaceutical company purposefully driven to save sight and improve eye care, announced results for the three-month period ended March 31, 2024, and an overview of the Company’s progress.
May 8, 2024
·
12 min read
Oculis Publishes Invitation to the Annual General Meeting - April 29, 2024
Oculis Holding AG, published the invitation to the 2024 Annual General Meeting, which will be held on 29 May 2024 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:30 p.m. CEST / 9:30 a.m. EDT.
April 29, 2024
·
1 min read
Genetown
Oculis to Present at Upcoming February 2024 Investor Conferences
Oculis Holding AG, a global biopharmaceutical company purposefully driven to save sight and improve eye care, announced that Oculis’ management will be attending and presenting at the following upcoming investor conferences:
January 29, 2024
·
1 min read
Business
Oculis Publishes Consolidated Q2 Financial Statements and MD&A
August 29, 2024
·
1 min read
1 of 13
Next
